GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

Adults should discuss with their doctors about whether this vaccine is necessary. It is recommended that adults 50 and older ...

The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.

Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179) has released an update. Jiangsu Recbio Technology has launched a phase III clinical trial in China for its novel shingles vaccine, REC610 ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected absent ...

Medically reviewed by Jonathan B. Jassey, DO Varicella-zoster virus (VZV) is the virus that causes chickenpox and shingles.

but also that getting a shingles vaccine can significantly lower the risk of developing dementia later. The remarkable thing about the study in Wales was that they were using the original ...

Based upon these results, Curevo will advance amezosvatein into global Phase 3 trials in 2025 to address a market for shingles vaccination currently exceeding $4 billion annually. Amezosvatein and ...

asked Harris. “Preventing shingles through vaccination may, therefore, be one strategy to slow dementia progression in those exhibiting underlying neuropathology of dementia.” The industry-funded ...

By Keith Roach, M.D. TITLE: 63-year-old debates getting shingles and chicken pox vaccines---DEAR DR. ROACH: A few months ago, yo ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected ...